Unique ID issued by UMIN | UMIN000014009 |
---|---|
Receipt number | R000016317 |
Scientific Title | A phase 1 clinical pharmacological study with repeated oral doses of KAG-308 |
Date of disclosure of the study information | 2014/05/20 |
Last modified on | 2014/10/14 10:58:13 |
A phase 1 clinical pharmacological study with repeated oral doses of KAG-308
A phase 1 clinical pharmacological study of KAG-308
A phase 1 clinical pharmacological study with repeated oral doses of KAG-308
A phase 1 clinical pharmacological study of KAG-308
Japan |
Ulcerative Colitis
Gastroenterology |
Others
NO
To assess the safety and pharmacokinetics of repeated oral doses (after meals, twice a day, for 5 days) of KAG-308 in healthy adult male subjects.
Safety
Safety
1. Body weight
2. Vital sign
3. Clinical test
4. Electrocardiogram
5. Adverse event
Pharmacokinetics
1. Changes over time in plasma concentration of KAG-308 and pharmacokinetic parameters
2. Urinary concentration of KAG-308 and the metabolites, and the excretion rate
3. Search for plasma unknown metabolites
Interventional
Parallel
Randomized
Single blind -participants are blinded
Placebo
4
Treatment
Medicine |
KAG-308 40 ug
KAG-308 80 ug
KAG-308 160 ug
Placebo
20 | years-old | <= |
45 | years-old | > |
Male
1. Weight 50 kg or more
2. BMI 18.5 or more, and less than 25.0
3. Japanese
1. The subject with failure or medical history of central nervous system disease, cardiac disease, or failure of cardiovascular, respiratory, blood and hematopoietic function system, gastrointestinal system, liver and renal function, thyroid function, pituitary function, adrenal function, etc. And the subject concluded by principal investigator (or sub investigators) difficult to ensure safety during the study.
2. The subject who meet the criteria of "clinical laboratory test, vital sign, 12 lead electrocardiograms".
3. The subject who tested positive after either HIV test, HBV test, HCV test, syphilis test, or tuberculosis test.
4. The subject with medical history of gastrointestinal tract symptom or gastrointestinal tract resection that affects pharmacokinetics.
5. The subject who is using drug or receiving therapy.
6. The subject with drug allergy or medical history.
7. The subject who felt sick at the time of blood donation or blood collection.
8. The subject who had been taken blood (blood donation, etc.) of more than 400 mL 90 days before the starting day of administration of the study drug, or the subject with the annual volume of blood collection more than 1200 mL including this study.
9. The subject who cannot stop either drinking alcohol during hospitalization or smoking from the day before the date of admission until the day of discharge.
10. The subject who tested positive on a urine abusable drug test.
11. The subject who is administered other study drug within 112 days past (16 weeks) before the scheduled administration date of the study drug.
12. The stuff of the institution or employees of the sponsor.
13. The subject who participated in the clinical trial of KAG-308 in the past, and take a dose of study drug.
30
1st name | |
Middle name | |
Last name | Akira Takahashi |
Kaken Pharmaceutical Co., LTD
Clinical Development Department
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, Japan
03-5977-5111
TAKAHASHI_AKIRA@kaken.co.jp
1st name | |
Middle name | |
Last name | Kaken Pharmaceutical Co., LTD |
Kaken Pharmaceutical Co., LTD
Clinical Development Department
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, Japan
03-5977-5111
KAMIYASHIKI_TSUTOMU@kaken.co.jp
Kaken Pharmaceutical Co., LTD
Kaken Pharmaceutical Co., LTD
Profit organization
NO
2014 | Year | 05 | Month | 20 | Day |
Unpublished
Completed
2014 | Year | 05 | Month | 01 | Day |
2014 | Year | 05 | Month | 22 | Day |
2014 | Year | 05 | Month | 20 | Day |
2014 | Year | 10 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016317
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |